Skyclarys

Active Ingredient(s): Omaveloxolone
FDA Approved: * February 28, 2023
Pharm Company: * REATA PHARMS
Category: Neurological Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Skyclarys 50 mg Oral Capsule
NDC: 73179-250
Labeler:
Reata Pharmaceuticals, Inc